INS and diabetes mellitus: Several management options for diabetes such as insulin releasers, insulin sensitizers, sulfonylureas and biagunides, α‐amylase and α‐glucosidase inhibitors are associated with serious shortcomings like limited and decreased efficacy over time and ineffectiveness against some long‐term diabetic complications.